A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
OBJECTIVES: HIV-1-specific CD8 T cells are considered to be critical in anti-HIV responses. It is important to quantify these cells and to determine their antigenic targets. Here quantification of interferon (IFN)-gamma secreting, virus-specific cells was achieved with an enzyme linked immuno spot (...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1999
|
_version_ | 1797098676668071936 |
---|---|
author | Larsson, M Jin, X Ramratnam, B Ogg, G Engelmayer, J Demoitie, M Mcmichael, A Cox, W Steinman, R Nixon, D Bhardwaj, N |
author_facet | Larsson, M Jin, X Ramratnam, B Ogg, G Engelmayer, J Demoitie, M Mcmichael, A Cox, W Steinman, R Nixon, D Bhardwaj, N |
author_sort | Larsson, M |
collection | OXFORD |
description | OBJECTIVES: HIV-1-specific CD8 T cells are considered to be critical in anti-HIV responses. It is important to quantify these cells and to determine their antigenic targets. Here quantification of interferon (IFN)-gamma secreting, virus-specific cells was achieved with an enzyme linked immuno spot (ELISPOT) assay. METHODS: Peripheral blood mononuclear cells (PBMC) were infected with recombinant vaccinia vectors expressing HIV-1 genes (gag, pol, env or nef) and added to wells precoated with anti-IFN-gamma monoclonal antibodies. Spot forming cells (SFC), i.e. antigen-specific T cells were detected 24 h later by the addition of biotinylated anti-IFN-gamma monoclonal antibodies, followed by avidin-bound biotinylated horseradish peroxidase. RESULTS: In a cohort of 19 patients, of whom 15 were on highly active antiretroviral therapy, 18 had primed T cells directed against one or more HIV-1 antigens (P < 0.0001). Pol-specific T cells routinely dominated the CD8 response with frequencies up to 2000 SFC per 10(6) PBMC. In HLA A*0201-positive patients, the vaccinia vectors detected much higher frequencies of SFC than haplotype-restricted peptides. Elimination of CD8 T cells resulted in > 90% loss of antigen-specific SFC when vaccinia virus was used as a vector. The number of CD8 SFC exceeded the number of memory cells detected in limiting dilution assays by > 1 log10, whereas a correlation was found between the frequency of effector cells detected by both ELISPOT and MHC class I peptide tetramer assays. CONCLUSIONS: Vaccinia virus vectors used in ELISPOT assays are useful for determining the frequency and specificity of CD8 T cells for individual HIV-1 gene products. The dominance of cytolytic T lymphocytes (CTL) recognizing pol proteins suggests that this antigen should be considered in vaccine strategies. |
first_indexed | 2024-03-07T05:13:00Z |
format | Journal article |
id | oxford-uuid:dc37c992-ea9f-44d6-b212-417d381df522 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T05:13:00Z |
publishDate | 1999 |
record_format | dspace |
spelling | oxford-uuid:dc37c992-ea9f-44d6-b212-417d381df5222022-03-27T09:16:08ZA recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dc37c992-ea9f-44d6-b212-417d381df522EnglishSymplectic Elements at Oxford1999Larsson, MJin, XRamratnam, BOgg, GEngelmayer, JDemoitie, MMcmichael, ACox, WSteinman, RNixon, DBhardwaj, NOBJECTIVES: HIV-1-specific CD8 T cells are considered to be critical in anti-HIV responses. It is important to quantify these cells and to determine their antigenic targets. Here quantification of interferon (IFN)-gamma secreting, virus-specific cells was achieved with an enzyme linked immuno spot (ELISPOT) assay. METHODS: Peripheral blood mononuclear cells (PBMC) were infected with recombinant vaccinia vectors expressing HIV-1 genes (gag, pol, env or nef) and added to wells precoated with anti-IFN-gamma monoclonal antibodies. Spot forming cells (SFC), i.e. antigen-specific T cells were detected 24 h later by the addition of biotinylated anti-IFN-gamma monoclonal antibodies, followed by avidin-bound biotinylated horseradish peroxidase. RESULTS: In a cohort of 19 patients, of whom 15 were on highly active antiretroviral therapy, 18 had primed T cells directed against one or more HIV-1 antigens (P < 0.0001). Pol-specific T cells routinely dominated the CD8 response with frequencies up to 2000 SFC per 10(6) PBMC. In HLA A*0201-positive patients, the vaccinia vectors detected much higher frequencies of SFC than haplotype-restricted peptides. Elimination of CD8 T cells resulted in > 90% loss of antigen-specific SFC when vaccinia virus was used as a vector. The number of CD8 SFC exceeded the number of memory cells detected in limiting dilution assays by > 1 log10, whereas a correlation was found between the frequency of effector cells detected by both ELISPOT and MHC class I peptide tetramer assays. CONCLUSIONS: Vaccinia virus vectors used in ELISPOT assays are useful for determining the frequency and specificity of CD8 T cells for individual HIV-1 gene products. The dominance of cytolytic T lymphocytes (CTL) recognizing pol proteins suggests that this antigen should be considered in vaccine strategies. |
spellingShingle | Larsson, M Jin, X Ramratnam, B Ogg, G Engelmayer, J Demoitie, M Mcmichael, A Cox, W Steinman, R Nixon, D Bhardwaj, N A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. |
title | A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. |
title_full | A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. |
title_fullStr | A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. |
title_full_unstemmed | A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. |
title_short | A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. |
title_sort | recombinant vaccinia virus based elispot assay detects high frequencies of pol specific cd8 t cells in hiv 1 positive individuals |
work_keys_str_mv | AT larssonm arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT jinx arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT ramratnamb arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT oggg arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT engelmayerj arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT demoitiem arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT mcmichaela arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT coxw arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT steinmanr arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT nixond arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT bhardwajn arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT larssonm recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT jinx recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT ramratnamb recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT oggg recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT engelmayerj recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT demoitiem recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT mcmichaela recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT coxw recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT steinmanr recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT nixond recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals AT bhardwajn recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals |